Treatment of Advanced Thyroid Cancer

[1]  S. Larson,et al.  Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer. , 2013, The New England journal of medicine.

[2]  S. Larson,et al.  Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans. , 2012, Thyroid : official journal of the American Thyroid Association.

[3]  S. Carty,et al.  American Thyroid Association statement on the essential elements of interdisciplinary communication of perioperative information for patients undergoing thyroid cancer surgery. , 2011, Thyroid : official journal of the American Thyroid Association.

[4]  R. Kelley,et al.  Evidence for drugs and biomarkers in oncology guidelines (GLs): A survey of the National Comprehensive Cancer Network (NCCN) colon cancer panel. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[5]  N. Lee,et al.  The role of external beam radiotherapy in the treatment of papillary thyroid cancer. , 2006, Endocrine-related cancer.

[6]  E. Baudin,et al.  Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. , 2006, The Journal of clinical endocrinology and metabolism.

[7]  S. Larson,et al.  Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. , 2001, Thyroid : official journal of the American Thyroid Association.